SGP

30.8300.16%
CP

Chetan Pujara

Chief Research & Development Officer

Dr. Chetan Pujara, Ph.D., is Chief Research & Development Officer of SpyGlassPharma, Inc. from February 2025. Dr. Pujara has many years of leadership experience in pharmaceutical and drug-device combination product development across ophthalmic, neurological, dermatological and infectious disease areas. An accomplished pharmaceutical executive, Dr. Pujara has led global organizations that contributed to the development of market-leading products, including Ozurdex, Durysta, Latisse, Qulipta, Ubrelvy and Refresh eye drops. He holds multiple U.S. and international patents and has extensive experience in global regulatory filings including with the FDA, EMA, NMPA and ANVISA. Prior to joining SpyGlass Pharma, Dr. Pujara held key leadership roles at Abbott, Allergan and AbbVie and most recently, Osanni, where he served as Chief Development Officer. He is a member of the United States Pharmacopeia Council of Experts and has previously served as board member of industry-academia consortia including National Science Foundation’s Center for Pharmaceutical Processing Research. Dr. Pujara holds a B.Pharm from Birla Institute of Technology and Science, Pilani and a Ph.D. in Pharmaceutical Sciences from Purdue University.

Positions